EIKN – eikon therapeutics, inc. (US:NASDAQ)

News

EIKN (EIKN) was downgraded by Wall Street Zen from "hold" to "sell".
EIKN (EIKN) had its "underperform" rating reaffirmed by Wedbush. They now have a $7.00 price target on the stock.
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
EIKN (EIKN) was upgraded by Wall Street Zen from "sell" to "hold".
EIKN (EIKN) was downgraded by Wall Street Zen from "hold" to "sell".
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com